New research reveals a statistical technique used in Alzheimer's drug trials inflates clinical efficacy claims by 29x.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results